Sofosbuvir, Velpatasvir, and Voxilaprevir for Treatment of Recurrent Hepatitis C Virus Infection After Liver Transplantation-Reference-Cited by-同舟云学术

Sofosbuvir, Velpatasvir, and Voxilaprevir for Treatment of Recurrent Hepatitis C Virus Infection After Liver Transplantation

Published:2018-11-14 Issue:12 Volume:2 Page:1446-1450
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatol Commun

Author:

Cardona‐Gonzalez Maria G.¹,Goldman Jason D.¹²,Narayan Lawrence¹,Brainard Diana M.³,Kowdley Kris V.¹

Affiliation:

1. Organ Transplant and Liver Center Swedish Medical Center Seattle WA

2. Division of Infectious Diseases Swedish Medical Center Seattle WA

3. Gilead Sciences Foster City CA

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1280

Reference9 articles.

1. Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection

2. Efficacy of Sofosbuvir Plus Ribavirin With or Without Peginterferon-Alfa in Patients With Hepatitis C Virus Genotype 3 Infection and Treatment-Experienced Patients With Cirrhosis and Hepatitis C Virus Genotype 2 Infection

3. Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis

4. AASLD‐IDSA.HCV guidance: recommendations for testing managing and treating hepatitis C.https://www.hcvguidelines.org. Accessed August 2017 and May 2018.

5. Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing HBV and HCV Infection Pre- and Post-liver Transplant;Journal of Clinical and Experimental Hepatology;2024-03

2. HBV and HCV Infection Prophylaxis in Liver Transplant Recipients;Infectious Diseases;2023-12-20

3. Sofosbuvir más glecaprevir/pibrentasvir como terapia de rescate postrasplante hepático en pacientes con exposición previa a inhibidores de NS5A. Serie de casos;Gaceta Médica de México;2023-09-21

4. Glecaprevir/pibrentasvir + sofosbuvir for post-liver transplant recurrent hepatitis C virus treatment;World Journal of Hepatology;2023-02-27

5. Real-World Therapeutic Outcomes of Direct-Acting Antiviral Regimens and Formidable Challenges;Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives;2023-01